Rocket Pharmaceuticals, Inc. (RCKT) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 1.04 |
| FCF Yield | -86.3% |
| Altman Z-Score | -3.55 (distress) |
| Sector P/E (Healthcare) | 21.7 |
RCKT overview · RCKT earnings · RCKT KPIs · RCKT investor relations · RCKT ownership · RCKT peers · RCKT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.